Reading time: 5 minutes Karli Norville Immune checkpoint inhibitors (ICIs) have been so impactful in the treatment of cancer in recent years that the basic research supporting their development was the subject of the 2018 Nobel Prize in Physiology… Read on blog or Reader OncoBites Read on blog or Reader The Balancing Act of Immune Checkpoint Inhibitors: Immune-related Adverse Events OncoBites May 1 Reading time: 5 minutes Karli Norville Immune checkpoint inhibitors (ICIs) have been so impactful in the treatment of cancer in recent years that the basic research supporting their development was the subject of the 2018 Nobel Prize in Physiology or Medicine (1). Despite their clinical success, the occurrence of immune-related adverse events (irAEs) within a […] Read more of this post Comment Like You can also reply to this email to leave a comment.

OncoBites © 2024. Manage your email settings or unsubscribe. Get the Jetpack app Subscribe, bookmark, and get real-time notifications - all from one app! Automattic, Inc. - 60 29th St. #343, San Francisco, CA 94110